drugset / Trial / NCT04774250
Noise-Induced Hearing Loss-Acute Exposure Treatment (UA)
Phase 2
Terminated
3 enrolled
Washington University School of Medicine
Gateway Biotechnology, Inc. · collabUnited States Department of Defense · collabUniversity of Texas · collab
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this study is to assess the safety and efficacy of zonisamide (ZNS) for the treatment of noise-induced hearing loss in adults.
Timeline
- Start
- 2021-11-10
- Primary completion
- 2022-12-23
- Completion
- 2022-12-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zonisamide | Other / unclassified | 100 mg | Oral |